Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

NCT00076102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Neurofibromatosis 1
Neurofibroma, Plexiform

Interventions

DRUG: Pirfenidone

Sponsor

National Cancer Institute (NCI)